NYSE - Nasdaq Real Time Price USD

Sempra (SRE)

72.01 +0.50 (+0.69%)
As of 2:15 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 1081415
Avg. Estimate 1.351.034.815.16
Low Estimate 1.280.964.745.07
High Estimate 1.41.094.915.35
Year Ago EPS 1.460.944.614.81

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 441010
Avg. Estimate 5.58B3.5B16.52B17.25B
Low Estimate 4.34B3.34B15.03B16.18B
High Estimate 6.22B3.63B18.63B20.02B
Year Ago Sales 6.56B3.33B16.72B16.52B
Sales Growth (year/est) -15.00%4.80%-1.20%4.40%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. 1.380.881.011.12
EPS Actual 1.460.941.081.13
Difference 0.080.060.070.01
Surprise % 5.80%6.80%6.90%0.90%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate 1.351.034.815.16
7 Days Ago 1.441.024.85.17
30 Days Ago 1.391.024.85.17
60 Days Ago 1.410.954.835.15
90 Days Ago 1.40.944.825.15

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --112
Up Last 30 Days --322
Down Last 7 Days --------
Down Last 30 Days 2--1--

Growth Estimates

CURRENCY IN USD SREIndustrySectorS&P 500
Current Qtr. -7.50%----0.30%
Next Qtr. 9.60%----9.80%
Current Year 4.30%----4.50%
Next Year 7.30%----13.40%
Next 5 Years (per annum) 5.90%----11.06%
Past 5 Years (per annum) 10.27%------

Research Analysis

Analyst Price Targets

75.00
82.90 Average
72.01 Current
89.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Morgan Stanley: Equal-Weight to Equal-Weight 3/21/2024
Maintains Barclays: Overweight to Overweight 3/14/2024
Reiterates RBC Capital: Outperform to Outperform 3/6/2024
Maintains Mizuho: Buy to Buy 1/25/2024
Maintains Barclays: Overweight to Overweight 1/22/2024
Upgrade BMO Capital: Market Perform to Outperform 1/11/2024

Related Tickers